In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale
Authors
Keywords
-
Journal
SEMINARS IN THROMBOSIS AND HEMOSTASIS
Volume -, Issue -, Pages -
Publisher
Georg Thieme Verlag KG
Online
2023-10-19
DOI
10.1055/s-0043-1776003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer
- (2023) Alok A Khorana et al. Journal for ImmunoTherapy of Cancer
- Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer
- (2023) Chiara A. Cella et al. JAMA Network Open
- Cancer-associated venous thromboembolism
- (2022) Alok A. Khorana et al. Nature Reviews Disease Primers
- Growth Differentiation Factor-15, High-Sensitivity Cardiac Troponin T, and N-Terminal pro-B-type Natriuretic Peptide for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy
- (2022) Danielle Carole Roy et al. THROMBOSIS AND HAEMOSTASIS
- Cancer genetic alterations and risk of venous thromboembolism
- (2022) Simon Mantha et al. THROMBOSIS RESEARCH
- Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer
- (2022) Shady N. Garas et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Evaluation of the Padua Prediction Score ability to predict venous thromboembolism in Israeli non-surgical hospitalized patients using electronic medical records
- (2022) O. Lavon et al. Scientific Reports
- ABO blood group type and risk of venous thromboembolism in patients with cancer
- (2022) Cornelia Englisch et al. Blood Advances
- Risk factors for rebleeding and long-term outcomes in patients with head and neck cancer bleeding: a multicenter study
- (2022) Chih-Kai Wang et al. BMC CANCER
- Systematic review of venous thromboembolism risk categories derived from Caprini scores
- (2022) Hilary Hayssen et al. Journal of Vascular Surgery-Venous and Lymphatic Disorders
- The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China
- (2022) Jiawen Yi et al. Thrombosis Journal
- Clinical impact of venous thromboembolism in non-small cell lung cancer patients receiving immunotherapy
- (2022) Birgitte Bjørnhart et al. THROMBOSIS RESEARCH
- HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment
- (2021) Kylee L. Martens et al. Blood Advances
- Venous Thromboembolism Incidence and Risk Assessment in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
- (2021) Oded Icht et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2021) Xiaohan Qian et al. Frontiers in Oncology
- Current status of treatment of cancer-associated venous thromboembolism
- (2021) Wei Xiong Thrombosis Journal
- Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
- (2021) Marek Z. Wojtukiewicz et al. CANCER AND METASTASIS REVIEWS
- Kras mutation as a risk factor for venous thromboembolism in patients with metastatic pancreatic cancer.
- (2021) Elena Serrano et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and risk of venous thromboembolism according to primary treatment type in women with endometrial cancer: a population-based study
- (2021) Jin-Sung Yuk et al. BMC CANCER
- Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitors
- (2021) Adi Kartolo et al. Immunotherapy
- Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration‐resistant cancer patients
- (2021) Vincenza Conteduca et al. INTERNATIONAL JOURNAL OF CANCER
- Growth differentiation factor‐15 for prediction of bleeding in cancer patients
- (2021) Frits I. Mulder et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study
- (2021) Brian J. Carney et al. Blood Advances
- A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer
- (2020) Sunil V. Patel et al. DISEASES OF THE COLON & RECTUM
- Impact of ALK Rearrangement on Venous and Arterial Thrombotic Risk in Non-Small Cell Lung Cancer
- (2020) Hanny Al-Samkari et al. Journal of Thoracic Oncology
- Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm
- (2020) Marek Z. Wojtukiewicz et al. Cancers
- Validation of Bleeding Risk Prediction Scores for Patients With Major Bleeding on Direct Oral Anticoagulants
- (2020) Stephanie Tchen et al. ANNALS OF PHARMACOTHERAPY
- Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy versus endocrine therapy alone: a systematic review and meta-analysis of randomized controlled trials
- (2020) Kyaw Zin Thein et al. BREAST CANCER RESEARCH AND TREATMENT
- Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer
- (2020) Vincenza Conteduca et al. BRITISH JOURNAL OF CANCER
- Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future
- (2020) Florian Moik et al. THROMBOSIS RESEARCH
- Venous thromboembolism in palliative care patients: what do we know?
- (2020) Simon Noble THROMBOSIS RESEARCH
- Incidence, risk factors and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy
- (2020) Florian Moik et al. BLOOD
- Risk of thromboembolism in patients with ALK‐ and EGFR‐mutant lung cancer: A cohort study
- (2020) Joanna Roopkumar et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
- (2019) Frits I. Mulder et al. HAEMATOLOGICA
- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bleeding incidence and risk factors among cancer patients treated with anticoagulation
- (2019) Dana E. Angelini et al. AMERICAN JOURNAL OF HEMATOLOGY
- TEMPORARY REMOVAL: ROS1-rearranged non-small cell lung cancer is associated with high rate of venous thromboembolism: analysis from a phase II, prospective, multicentre, two-arms trial (METROS)
- (2019) Rita Chiari et al. Clinical Lung Cancer
- Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug–Associated Thrombosis Among Patients With Multiple Myeloma
- (2019) Ang Li et al. Journal of the National Comprehensive Cancer Network
- The impact of pharmacological thromboprophylaxis and disease-stage on postoperative bleeding following colorectal cancer surgery
- (2019) Hiroyuki Ohta et al. World Journal of Surgical Oncology
- Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score
- (2019) Kristen M. Sanfilippo et al. AMERICAN JOURNAL OF HEMATOLOGY
- Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients
- (2019) Makoto Hiraide et al. Journal of Cardiology
- 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
- (2019) Dominique Farge et al. LANCET ONCOLOGY
- Varying effects of tyrosine kinase inhibitors on platelet function—A need for individualized CML treatment to minimize the risk for hemostatic and thrombotic complications?
- (2019) Suryyani Deb et al. Cancer Medicine
- Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors
- (2019) Yosuke Ando et al. INVESTIGATIONAL NEW DRUGS
- Risk of Ischemic Stroke and Major Bleeding in Patients with Atrial Fibrillation and Cancer
- (2019) Sara Aspberg et al. Journal of Stroke & Cerebrovascular Diseases
- Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study
- (2019) Feifei Dou et al. THROMBOSIS RESEARCH
- The EGFR-rearranged adenocarcinoma is associated with a high rate of venous thromboembolism
- (2019) Jing Wang et al. Annals of Translational Medicine
- Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: Clinical consequences
- (2018) Audrey Bellesoeur et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis
- (2018) M. Di Nisio et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer
- (2018) Gary H. Lyman et al. THROMBOSIS RESEARCH
- Evaluation of the ThroLy score for the prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies in clinical practice
- (2018) Joanna Rupa-Matysek et al. Cancer Medicine
- A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts
- (2018) Ingrid Pabinger et al. Lancet Haematology
- The location, histologic type, and stage of lung cancer are associated with bleeding during endobronchial biopsy
- (2018) Saibin Wang et al. Cancer Management and Research
- Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study
- (2018) Konstantinos Syrigos et al. ONCOLOGIST
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
- (2018) Norbaini Abdol Razak et al. Cancers
- Risk of Arterial Thromboembolism in Patients With Cancer
- (2017) Babak B. Navi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ABO Blood Group and Risk of Thromboembolic and Arterial DiseaseCLINICAL PERSPECTIVE
- (2016) Senthil K. Vasan et al. CIRCULATION
- Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism
- (2016) Adi J. Klil-Drori et al. EUROPEAN UROLOGY
- Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old
- (2016) Frederic Bigot et al. INVESTIGATIONAL NEW DRUGS
- External validation of the IMPROVE Bleeding Risk Assessment Model in medical patients
- (2016) David J. Rosenberg et al. THROMBOSIS AND HAEMOSTASIS
- Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer
- (2015) S. Ades et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Validation of the Caprini Venous Thromboembolism Risk Assessment Model in Critically Ill Surgical Patients
- (2015) Andrea T. Obi et al. JAMA Surgery
- Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study
- (2014) Ilana Kopolovic et al. ANNALS OF HEMATOLOGY
- GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
- (2013) Lars Wallentin et al. PLoS One
- Mutations in NSCLC and their link with lung cancer-associated thrombosis: A case-control study
- (2013) Luis Corrales-Rodriguez et al. THROMBOSIS RESEARCH
- Venous thromboembolism risk and erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis
- (2013) Sheng Gao et al. TUMOR BIOLOGY
- Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trials
- (2012) F. Petrelli et al. ANNALS OF ONCOLOGY
- Androgen-Deprivation Therapy for Nonmetastatic Prostate Cancer Is Associated With an Increased Risk of Peripheral Arterial Disease and Venous Thromboembolism
- (2012) Jim C. Hu et al. EUROPEAN UROLOGY
- Risk of venous thromboembolic events associated with VEGFR-TKIs: A systematic review and meta-analysis
- (2012) Wei-Xiang Qi et al. INTERNATIONAL JOURNAL OF CANCER
- Epidemiology and pathophysiology of cancer-associated thrombosis
- (2010) S Noble et al. BRITISH JOURNAL OF CANCER
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Development and validation of a predictive model for chemotherapy-associated thrombosis
- (2008) A. A. Khorana et al. BLOOD
- Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
- (2008) Shobha Rani Nalluri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now